These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris. Jarratt MT, Jones TM, Chang-Lin JE, Tong W, Berk DR, Lin V, Kaoukhov A. J Drugs Dermatol; 2016 Oct 01; 15(10):1250-1259. PubMed ID: 27741344 [Abstract] [Full Text] [Related]
16. An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color. El-Kashlan N, Cices A, Kaufman B, Da Rosa JC, Sanabria-Gonzalez I, Khattri S, Alexis A. J Drugs Dermatol; 2024 Jun 01; 23(6):410-417. PubMed ID: 38834229 [Abstract] [Full Text] [Related]